New meningitis vax arrives in Africa

A newly approved meningitis vaccine developed by an international consortium that includes Bill Gates and the WHO is being deployed as the first line of defense against the meningitis epidemics that rage through Africa. "This is pretty close to a revolution in terms of controlling meningitis," Daniel Berman, deputy director of Medecin Sans Frontiere's Access for Essential Medicines campaign, told the Associated Press. "With this new vaccine, we will be able to plan ahead to prevent outbreaks." Story

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.